Radnor Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Radnor Capital Management, LLC

  • $598 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022
BUY
$595.12 - $698.43 $35,707 - $41,905
60 Added 9.38%
700 $489,000
Q4 2021

Jan 20, 2022
BUY
$543.48 - $670.97 $108,696 - $134,194
200 Added 45.45%
640 $404,000
Q3 2021

Oct 26, 2021
BUY
$574.03 - $680.96 $252,573 - $299,622
440 New
440 $266,000

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
84.6M
Call Options Held
1.29M
Put Options Held
1.47M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $71.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Radnor Capital Management, LLC Portfolio

Follow Radnor Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email